Market Insights:
Psoriasis is a highly common chronic skin condition. Market Research Future's (MRFR) in-
depth market report on the global psoriasis treatment market has disclosed that the market
is anticipated to witness a promising CAGR of 7.3% during the forecast period of 2016 to
2022. The social stigma and discomfort that is associated with psoriasis is expected to
promote swift market growth. Valued at USD 7 Bn at the beginning of 2016, the global
market is expected to witness increased revenue which results in an approximate evaluation
of over USD 10 bn by the end of the assessment period.
Rising awareness and screening for psoriasis is the leading factor driving growth in the
demand for psoriasis treatment. This chronic condition is exacerbated by several factors
which can vary from patient to patient, thus further increasing the demand for appropriate
and effective treatment options. Increasing exposure to chemicals and polluted
environments have resulted in an increase in the diagnosis of psoriasis. Presently, all
treatment options are temporary in nature or need ongoing patient involvement with no
concrete cure. Drugs for psoriasis treatment carry a high cost which will hamper market
growth. However, increasing adoptions of alternative psoriasis treatments, and the race
among market players to develop an effective psoriasis treatment solution will lead to
market opportunities.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/2769
Key Players:
Market leaders who participate in the competitive landscape of the global psoriasis
treatment market include Eli Lilly, Novartis International AG, Johnson & Johnson, Pfizer Inc.,
Merck and Co Inc., Amgen and AbbVie.
Market Segmentation:
The global psoriasis treatment market is segmented in MRFR's competitive analysis on the
basis of mechanism of action, route of administration, drug types, and region. Based on
mechanism of action, the market is segmented into interleukin blockers, phosphodiesterase
inhibitors, TNF inhibitors, and others.
By route of administration, the market is divided between oral, injectable, and topical. Oral
treatment options are highly popular and capture around 40% of the global market.
On the basis of drug types, the market is segmented into biologics and small molecules.
Globally, the market is divided into the Americas, Europe, Asia-Pacific (APAC), and the
Middle East and Africa.
Regional Analysis:
Due to the presence of North America, the Americas account for the largest share of the
global market. The presence of several market players and a high patient population
afflicted with psoriasis is expected to lead to increased revenue generated for market
growth. Moreover, the awareness about this condition is quite high in the region and has led
to an increased demand for effective treatment options. Increasing R&D activities to develop
a long-term solution for psoriasis is expected to facilitate market expansion opportunities.
Meanwhile, the Asia Pacific is the fastest growing region due to the swiftly developing
healthcare sector and the growing awareness regarding conditions like psoriasis which has
resulted in increased demand. The affinity for natural skin care methods is expected to
reveal effective alternate treatment strategies that may assist future market growth.
Latest Industry News:
Eli Lilly & Company in Korea has received government approval from the Ministry of Health
& Welfare for the reimbursement for its psoriasis treatment drug Taltz.
Access Full Report @ https://www.marketresearchfuture.com/reports/psoriasis-
treatment-market-2769
Table of Contents
1 Introduction
2 Research Methodology
3 Market Dynamics